APQ Health Inc. Launches AI-Driven Cardiovascular Imaging Technology

Los Angeles, California

APQ Health, a new health-tech startup founded by developers of Autoplaque software, holds the exclusive worldwide license for the Autoplaque software—an AI-enabled tool for the analysis of coronary plaques from CT angiography images. Autoplaque software—a cutting-edge AI software platform developed at Cedars-Sinai by the APQ Health founders —delivers automated, AI-powered quantitative analysis of atherosclerotic plaque from coronary CT angiography, providing physicians with a powerful tool for risk prediction and guiding treatment. Backed by years of peer-reviewed research and clinical validation from investigators across the country, Autoplaque software represents a major step forward in noninvasive cardiovascular imaging. APQ Health Inc. is focused on transforming this innovation into physician-ready tools that support clinical decision-making.

Disclosures: Cedars-Sinai is an equity stakeholder in APQ Health.